Act 720 - DRUG TAKE-BACK ACT
- Section 410 ILCS 720/1 - Short title
- Section 410 ILCS 720/5 - Findings
- Section 410 ILCS 720/10 - Definitions
- Section 410 ILCS 720/15 - Participation in a drug take-back program
- Section 410 ILCS 720/20 - Identification of covered manufacturers
- Section 410 ILCS 720/25 - Drug take-back program requirements
- Section 410 ILCS 720/30 - Manufacturer program operator requirements
- Section 410 ILCS 720/35 - Drug take-back program approval
- Section 410 ILCS 720/40 - Changes or modifications to the approved manufacturer drug take-back program
- Section 410 ILCS 720/45 - Drug take-back program promotion
- Section 410 ILCS 720/50 - Annual program report
- Section 410 ILCS 720/55 - Manufacturer drug take-back program funding
- Section 410 ILCS 720/60 - Registration fee
- Section 410 ILCS 720/65 - Rules; enforcement; penalties
- Section 410 ILCS 720/70 - Antitrust immunity
- Section 410 ILCS 720/75 - Public disclosure
- Section 410 ILCS 720/90 - Home rule
- Section 410 ILCS 720/95 - (Amendatory provisions; text omitted)
- Section 410 ILCS 720/100 - (Amendatory provisions; text omitted)
- Section 410 ILCS 720/999 - Effective date